Response to 1st-line Treatment with BR or R-CHOP in Patients with Indolent non-Hodgkin’s Lymphoma: First Outcome Data from the German Prospective TLN Registry.

Knauf, W.U., Abenhardt, W., Hansen, R., Grugel, R., Harde, J., Marschner, N., 2013.

Blood 122(21), 3036.

Studie: TLN; Indikation: Hämoblastosen; Jahr: 2013; Veranstaltung: ASH; Journal: Blood

iOMEDICO AG
Hanferstraße 28
79108 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com